ACTEMRA is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Tocilizumab.
Product ID | 50242-135_07e066f7-664a-4949-9d91-f8a17e022f45 |
NDC | 50242-135 |
Product Type | Human Prescription Drug |
Proprietary Name | ACTEMRA |
Generic Name | Tocilizumab |
Dosage Form | Injection, Solution, Concentrate |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2010-01-08 |
Marketing Category | BLA / BLA |
Application Number | BLA125276 |
Labeler Name | Genentech, Inc. |
Substance Name | TOCILIZUMAB |
Active Ingredient Strength | 20 mg/mL |
Pharm Classes | Interleukin 6 Receptor Antagonists [MoA],Interleukin-6 Receptor Antagonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2010-01-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125276 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-01-08 |
Marketing Category | BLA |
Application Number | BLA125276 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-01-08 |
Marketing End Date | 2017-04-06 |
Ingredient | Strength |
---|---|
TOCILIZUMAB | 20 mg/mL |
SPL SET ID: | 2e5365ff-cb2a-4b16-b2c7-e35c6bf2de13 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
50242-135 | ACTEMRA | tocilizumab |
50242-136 | ACTEMRA | tocilizumab |
50242-137 | ACTEMRA | tocilizumab |
50242-138 | Actemra | tocilizumab |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ACTEMRA 78227672 2984926 Live/Registered |
CHUGAI SEIYAKU KABUSHIKI KAISHA 2003-03-19 |